You are here

Policy

 

Ethicists from the University of Basel have developed a biosecurity framework specific to neurotechnology while calling for a ban on dual-use technology with the aim of regulating mental privacy and integrity of humans. Findings were published in Neuron.

As cyberattack become increasingly common incidents, healthcare professionals must push security to the forefront. In a presentation given at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, Jim Whitfill, CMO of innovation Health Partners and president of Lumetis, described the current cybersecurity environment and detailed how professionals can take steps toward improving privacy.

Despite increased prevention efforts and longer lifespans, heart failure rates are at a high in the United Kingdom and are continuing to climb, according to new research published in The Lancet.

The U.S. Food and Drug Administration (FDA) has approved a remote feature allowing programming sessions given through telehealth platforms to patients who have had at least six months of experience with their cochlear implant sound processor.

The U.S. Food and Drug Administration (FDA) has approved the first digital pill with an ingestion tracking system to tell physicians whether patients have taken their medication.

 

Recent Headlines

FDA will award you $40,000 to develop crowd-sourcing Naloxone app

The FDA is offering a skilled coder $40,000 to make a mobile app that could help people experiencing an opioid overdose find a potentially life-saving dose of Naloxone.

 
CHIME announces new appointments to leadership positions

The College of Healthcare Information Management Executives (CHIME) has announced the newest appointments to its board of trustees, board of directors and elected officers for 2018.

Quality Payment Program introduces choices for physicians in 2017

A blog post by Andy Slavitt, Acting Administrator of CMS, highlights the choices eligible physicians will have for the Quality Payment Program starting on Jan. 1, 2017.

FDA recalls the INRatio and INRatio2 PT/INR monitoring systems

The FDA has announced that Alere has recalled their INRatio and INRatio2 PT/INR monitoring systems.

PuraPly products now available for Medicare reimbursement in 10 states

Following the decision by the National Government Services to end its local coverage determination for both cellular and tissue-based products, Organogenesis’s PuraPly and PuraPly Antimicrobial products for wound management will be eligible for Medicare coverage and reimbursement in 10 states.

EpiPen's 400 percent price increase has consumers and Congress confused and concerned

U.S. lawmakers are joining concerned parents in demanding to know: What is up with the sudden increase in the price of an EpiPen?

 
Device companies agree to pay $1 billion in user fees to FDA

Medical device companies will pay the FDA nearly $1 billion in user fees for five years beginning in October 2017 under the fourth reauthorization of the Medical Device User Fee & Modernization Act (MDUFA).

Pathway Health to get a tech upgrade through Virtual Health partnership

Pathway Health, a post-acute consulting firm, and Virtual Health, a population health management technology provider, have entered into a partnership that will provide Pathway with strategic consulting services to improve technology and payment models.

FDA guidance addresses when device makers need to report changes

Draft guidance from the Food and Drug Administration is seeking to clarify when medical device manufacturers need the agency’s approval to make changes to their products, potentially replacing guidance that had remained unchanged since 1997.

Q&A with AMDIS Award winner Peter Basch

Recently, the Association of Medical Directors of Information Systems (AMDIS) held their annual awards to recognize leaders in healthcare IT. Among those recipients was Peter Basch, MD, MACP, Senior Director for IT Quality and Safety, Research and National Health IT Policy at MedStar Health.

Pages